Prevention of postcataract endophthalmitis: Evidence-based medicine

Current Opinion in Ophthalmology

Volumn 23, Issue 1, 2012, Pages 19-25

  Yu, Charles Q ^a   Ta, Christopher N ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Antibiotics; Cataract; Endophthalmitis; Povidone iodine; Prophylaxis

Indexed keywords

AZITHROMYCIN; BESIFLOXACIN; CEFUROXIME; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; POLYMYXIN B; POVIDONE IODINE; QUINOLONE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL FLORA; BANDAGE; CATARACT EXTRACTION; CHEMOSIS; CLINICAL PROTOCOL; DRUG PENETRATION; ENDOPHTHALMITIS; EVIDENCE BASED MEDICINE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYPEREMIA; NONHUMAN; PENICILLIN RESISTANCE; POSTCATARACT ENDOPHTHALMITIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARD; STAPHYLOCOCCUS; SURGICAL INFECTION; SURGICAL RISK; SURGICAL TECHNIQUE; UNSPECIFIED SIDE EFFECT; POSTOPERATIVE COMPLICATION; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CATARACT EXTRACTION; DRUG RESISTANCE, MICROBIAL; ENDOPHTHALMITIS; EVIDENCE-BASED MEDICINE; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84856609043     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32834cd5a9     Document Type: Review

References (77)

1. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995; 113:1479-1496.
2. Kernt M, Kampik A. Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives. Clin Ophthalmol 2010; 4:121-135.
3. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991; 98:1769-1775.
4. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996; 122:1-17. (Pubitemid 26230889)
5. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol 1998; 43:193-224. (Pubitemid 28558270)
6. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Arch Ophthalmol 2005; 123:613-620. (Pubitemid 40695508)
7. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007; 33:978-988. This paper describes a prospective, randomized, multicenter, clinical trial evaluating the efficacy of preoperative topical levofloxacin and intracameral cefuroxime in reducing the risk of postoperative endophthalmitis. The study found that intracameral cefuroxime significantly decreased the risk of endophthalmitis following cataract surgery.
8. Ou JI, Ta CN. Endophthalmitis prophylaxis. Ophthalmol Clin North Am 2006; 19:449-456. (Pubitemid 44602343)
9. Kim JY, Ali R, Cremers SL, Henderson BA. Perioperative prophylaxis for postcataract extraction endophthalmitis. Int Ophthalmol Clin 2007; 47:1-14. (Pubitemid 46725800)
10. CiullaTA, StarrMB,Masket S.Bacterialendophthalmitis prophylaxis for cataract surgery: An evidence-based update. Ophthalmology 2002; 109:13-24. (Pubitemid 34027416)
11. Fintelmann RE, Naseri A. Prophylaxis of postoperative endophthalmitis following cataract surgery: Current status and future directions. Drugs 2010; 70:1395-1409.
12. Scott IU, Flynn HW Jr, Feuer W. Endophthalmitis after secondary intraocular lens implantation. A case-report study. Ophthalmology 1995; 102:1925-1931. (Pubitemid 26004450)
13. Mino de Kaspar H, Shriver EM, Nguyen EV, et al. Risk factors for antibioticresistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefes Arch Clin Exp Ophthalmol 2003; 241:730-733. (Pubitemid 37265815)
14. Wallin T, Parker J, Jin Y, et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg 2005; 31:735-741. (Pubitemid 40719417)
15. Fernandez-Rubio ME, Rebolledo-Lara L, Martinez-Garcia M, et al. The conjunctival bacterial pattern of diabetics undergoing cataract surgery. Eye 2010; 24:825-834.
16. Phillips WB 2nd, Tasman WS. Postoperative endophthalmitis in association with diabetes mellitus. Ophthalmology 1994; 101:508-518. (Pubitemid 24100575)
17. Doft BH, Wisniewski SR, Kelsey SF, Fitzgerald SG. Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol 2001; 119:650-656. (Pubitemid 32417370)
18. Hatch WV, Cernat G, Wong D, et al. Risk factors for acute endophthalmitis after cataract surgery: A population-based study. Ophthalmology 2009; 116:425-430. In this retrospective study of more than 440 000 consecutive cataract surgeries in Toronto, Canada, the authors reported that the overall incidence of endophthalmitis was 1.4 per 1000 surgeries. There was a 10-fold increase in the rate of endophthalmitis in those patients with capsular rupture.
19. Garcia-Arumi J, Fonollosa A, Sararols L, et al. Topical anesthesia: Possible risk factor for endophthalmitis after cataract extraction. J Cataract Refract Surg 2007; 33:989-992. (Pubitemid 46783870)
20. Al-Mezaine HS, Kangave D, Al-Assiri A, Al-Rajhi AA. Acute-onset nosocomial endophthalmitis after cataract surgery: Incidence, clinical features, causative organisms, and visual outcomes. J Cataract Refract Surg 2009; 35:643-649.
21. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 2000; 35:373-378. (Pubitemid 32634593)
22. Miller JJ, Scott IU, Flynn HW Jr, et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): Incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005; 139:983-987.
23. Lundstrom M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: A nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007; 114:866-870. (Pubitemid 46635845)
24. Wykoff CC, Parrott MB, Flynn HW Jr, et al. Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002- 2009). Am J Ophthalmol 2010; 150:392.e2-398.e2. The authors found in this retrospective study a decreasing rate of postoperative endophthalmitis from 1984 to 2009. The most recent incidence of postoperative endophthalmitis was 0.025% (2002-2009).
25. Thoms SS, Musch DC, Soong HK. Postoperative endophthalmitis associated with sutured versus unsutured clear corneal cataract incisions. Br J Ophthalmol 2007; 91:728-730. (Pubitemid 46846638)
26. Calladine D, Ward M, Packard R. Adherent ocular bandage for clear corneal incisions used in cataract surgery. J Cataract Refract Surg 2010; 36:1839- 1848.
27. Hovanesian JA. Cataract wound closure with a polymerizing liquid hydrogel ocular bandage. J Cataract Refract Surg 2009; 35:912-916.
28. Menabuoni L, Pini R, Rossi F, et al. Laser-assisted corneal welding in cataract surgery: Retrospective study. J Cataract Refract Surg 2007; 33:1608-1612. (Pubitemid 47299177)
29. Sim DA, Wong R, Griffiths MF. Injecting an air bubble at the end of sutureless cataract surgery to prevent inflow of ocular surface fluid. Eye 2007; 21:1444-1445. (Pubitemid 350066493)
30. Taban M, Sarayba MA, Ignacio TS, et al. Ingress of India ink into the anterior chamber through sutureless clear corneal cataract wounds. Arch Ophthalmol 2005; 123:643-648. (Pubitemid 40695512)
31. Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery. III: Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol 1984; 102:728-729. (Pubitemid 14138711)
32. Apt L, Isenberg SJ, Yoshimori R, et al. The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol 1995; 119:701-705.
33. Mino de Kaspar H, Chang RT, Singh K, et al. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol 2005; 123:161-165. (Pubitemid 40189701)
34. Ferguson AW, Scott JA, McGavigan J, et al. Comparison of 5% povidone- iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: A prospective randomised double blind study. Br J Ophthalmol 2003; 87:163-167. (Pubitemid 36152742)
35. Dereklis DL, Bufidis TA, Tsiakiri EP, Palassopoulos SI. Preoperative ocular disinfection by the use of povidone-iodine 5%. Acta Ophthalmol (Copenh) 1994; 72:627-630. (Pubitemid 24370775)
36. Wu PC, Li M, Chang SJ, et al. Risk of endophthalmitis after cataract surgery using different protocols for povidone-iodine preoperative disinfection. J Ocul Pharmacol Ther 2006; 22:54-61. (Pubitemid 43364081)
37. Trinavarat A, Atchaneeyasakul LO, Nopmaneejumruslers C, Inson K. Reduction of endophthalmitis rate after cataract surgery with preoperative 5% povidone-iodine. Dermatology 2006; 212 (Suppl 1):35-40.
38. TaCN, Singh K, Egbert PR, de Kaspar HM. Prospective comparative evaluation of povidone-iodine (10% for 5 min versus 5% for 1 min) as prophylaxis for ophthalmic surgery. J Cataract Refract Surg 2008; 34:171-172. (Pubitemid 350299779)
39. Mac Rae SM, Brown B, Edelhauser HF. The corneal toxicity of presurgical skin antiseptics. Am J Ophthalmol 1984; 97:221-232. (Pubitemid 14193170)
40. Kashiwagi K, Saito K, Wang YD, et al. Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery. Ophthalmologica 2001; 215:351-356. (Pubitemid 32786194)
41. Alp BN, Elibol O, Sargon MF, et al. The effect of povidone iodine on the corneal endothelium. Cornea 2000; 19:546-550. (Pubitemid 30460897)
42. Jiang J, Wu M, Shen T. The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol 2009; 28:119-124.
43. Hansmann F, Below H, Kramer A, et al. Prospective study to determine the penetration of iodide into the anterior chamber following preoperative application of topical 1.25% povidone-iodine. Graefes Arch Clin Exp Ophthalmol 2007; 245:789-793. (Pubitemid 46805608)
44. Shimada H, Arai S, Nakashizuka H, et al. Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone-iodine. Am J Ophthalmol 2011; 151:11.e11-17.e11.
45. Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2007 ASCRS member survey. J Cataract Refract Surg 2007; 33:1801-1805. (Pubitemid 47419240)
46. Masket S. Preventing, diagnosing, and treating endophthalmitis. J Cataract Refract Surg 1998; 24:725-726. (Pubitemid 28303002)
47. De Kaspar HM, Chang RT, Shriver EM, et al. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: A prospective randomized study. Ophthalmology 2004; 111:1352-1355. (Pubitemid 38844834)
48. Ta CN, Egbert PR, Singh K, et al. Prospective randomized comparison of 3- day versus 1-h preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 2002; 109:2036-2040; discussion 2031-2040. (Pubitemid 35222557)
49. Jensen MK, Fiscella RG, Moshirfar M, Mooney B. Third- and fourth-generation fluoroquinolones: Retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg 2008; 34:1460-1467.
50. Melo GB, Bispo PJ, YuMC, et al. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye 2011; 25:382-387; quiz 388.
51. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eye drops given by different methods before cataract surgery. J Cataract Refract Surg 2007; 33:59-62. (Pubitemid 46001538)
52. Gungor SG, Akova YA, Bozkurt A, et al. Aqueous humour penetration of moxifloxacin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. Br J Ophthalmol 2011; 95:1272-1275.
53. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eye drops given in different concentrations in a wick before cataract surgery. J Cataract Refract Surg 2008; 34:819-822. (Pubitemid 351626964)
54. Kim DH, Stark WJ, O'Brien TP, Dick JD. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 2005; 112:1992-1996. (Pubitemid 41551929)
55. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009; 116:1498-1501. In this prospective randomized study of patients undergoing intravitreal injections, there was no additional benefit of preoperative topical antibiotics in eliminating conjunctival bacterial flora when used in conjunction with povidone-iodine.
56. Halachmi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5. 0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg 2009; 35:2109-2114.
57. Vasavada AR, Gajjar D, Raj SM, Vasavada V. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: Prospective randomized triple-masked trial. Part 1: Aqueous concentration of moxifloxacin. J Cataract Refract Surg 2008; 34:1379-1382. (Pubitemid 352004125)
58. He L, Ta CN, Hu N, et al. Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. J Ocul Pharmacol Ther 2009; 25:373-378.
59. Moss JM, Nguyen D, Liu YI, et al. Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora. Ophthalmology 2008; 115:2013-2016.
60. Haas W, Pillar CM, Hesje CK, et al. Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae. J Antimicrob Chemother 2010; 65:1441-1447.
61. Proksch JW, Granvil CP, Siou-Mermet R, et al. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. J Ocul Pharmacol Ther 2009; 25:335-344.
62. McDonald MB, Protzko EE, Brunner LS, et al. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. Ophthalmology 2009; 116:1615.e1-1623.e1.
63. Yoshida J, Kim A, Pratzer KA, Stark WJ. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients. J Cataract Refract Surg 2010; 36:1499-1502.
64. Donnenfeld ED, Comstock TL, Proksch JW. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. J Cataract Refract Surg 2011; 37:1082-1089.
65. Norcross EW, Sanders ME, Moore Q 3rd, et al. Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillinresistant Streptococcus pneumoniae rabbit endophthalmitis. J Ocul Pharmacol Ther 2010; 26:237-243.
66. Kamalarajah S, Ling R, Silvestri G, et al. Presumed infectious endophthalmitis following cataract surgery in the UK: A case-control study of risk factors. Eye 2007; 21:580-586. (Pubitemid 46730703)
67. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006; 32:407-410. (Pubitemid 44313820)
68. Murjaneh S, Waqar S, Hale JE, et al. National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK. Br J Ophthalmol 2010; 94:1410-1411.
69. Sharifi E, Porco TC, Naseri A. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology 2009; 116:1887.e1-1896.e1.
70. Garcia-Saenz MC, Arias-Puente A, Rodriguez-Caravaca G, Banuelos JB. Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery ten-year comparative study. J Cataract Refract Surg 2010; 36:203-207.
71. Hariprasad SM, Shah GK, Mieler WF, et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 2006; 124:178-182. (Pubitemid 43247066)
72. Kampougeris G, Antoniadou A, Kavouklis E, et al. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol 2005; 89:628-631. (Pubitemid 40569724)
73. Garcia-Saenz MC, Arias-Puente A, Fresnadillo-Martinez MJ, Carrasco-Font C. Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin. J Cataract Refract Surg 2001; 27:1969-1974. (Pubitemid 33136177)
74. Miller D, Flynn PM, Scott IU, et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 2006; 124:479-483.
75. Major JC Jr, Engelbert M, Flynn HW Jr, et al. Staphylococcus aureus endophthalmitis: Antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol 2010; 149:278.e1-283.e1.
76. Shirodkar AR, Flynn HW, Alliman K, et al. The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria. Clin Ophthalmol 2010; 4:211-214.
77. Asbell PA, Colby KA, Deng S, et al. Ocular TRUST: Nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol 2008; 145:951-958.